Since the beginning of this unsurpassed crisis, the teams of sanofi-aventis have been mobilized working with the Authorities and teams on the ground to ensure the release of a first urgent financial aid of 100,000 Euros and considerable donations of medicines and vaccines. The Group will continue to do so.
"We are profoundly affected by the magnitude of the tragedy, which has struck Haiti, and we would like to express our sincere compassion to the families of the victims," declared Christopher A. Viehbacher, Chief Executive Officer, sanofi-aventis. "Solidarity is integral to the DNA of our Group and I consider it our responsibility as a worldwide diversified healthcare leader to respond to the essential health requirements of these victims, in dire need."
Sanofi-aventis has also called on the generosity of its employees worldwide to support the cause. The resulting donations will be matched by the Group. For each donated euro, the Group will donate an additional euro, multiplying by two the available fund.
Employees donations will help support the post-emergency programme driven by six associations, Aide MÃ©dicale Internationale, Care, the Red Cross, Handicap International, MÃ©decins du Monde and UNICEF, all of which are specialists experienced in extreme situations, are chosen partners of our Group and are already present in Haiti. These associations will ensure the co-ordination of all implemented actions in the best interest of the people affected.
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT : SAN) and in New York (NYSE : SNY). For more information, visit: www.sanofi-aventis.us or www.sanofi-aventis.com.